My account:




  remember me

Enter   Register
Information
All rights reserved. Any reprinting of materials of the site is possible only with the written permission of administration and with a direct hyperlink to this site.

Upcoming Events





ISPOR 16th Annual European Congress


2-6 November 2013 
Dublin, Ireland


The key topics of the Congress are as follows: 
         the Patient and HTA
         Early Engagement between Manufacturers, HTA Assessors and Regulators in Order to Provide Faster Access to New Technologies
         Should Multi-Criteria Decision Making Analysis (MCDA) Replace Cost Effectiveness Analysis (CEA) for Evaluation of Health Care Coverage Decisions  


Activities of the Russia HTA Chapter at the 16th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Dublin, Ireland, November 2-6, 2013



14 posters will be presented
   

How can the Russian pharma industry benefit and leverage population and patient data with local authorities?

12:15 14:00, Monday, November 4, 2013
The discussion will focus on the role of patient reported outcomes (PRO), expectations of different HTA agencies (with focus on UK) and the benefits of preparing PRO data for the industry and state. 
The meeting will be held in English.
Moderator: Mira Pavlovic, MD, Deputy Director for Health Technology Assessment, Haute Autorité de Santé (HAS), Saint-Denis La Plaine, France, EUnetHTA

New health reforms and HTA status in Russia, Ukraine, Belarus, Kazakhstan, and Armenia
18:00-19:00, Monday November 4, 2013
The forum will discuss main directions of the health care reforms in the CIS countries and the ways to make them efficient through implementing HTA. The forum will encourage HTA development and regional and international cooperation in the HTA field to support rational decision making in health care. Presented by ISPOR Russia HTA, Ukraine, Belarus, Armenia, and Kazakhstan Regional Chapters
Moderator: Vitaly V. Omelyanovskiy, MD, PhD, Professor, Director of Center for HTA, Russian Presidential Academy of National Economy & Public Administration, President of ISPOR Russia HTA Chapter   
 
Ways to optimize public funding for drug availability under present conditions
11:45-13:15, Tuesday, November 5, 2013
The meeting will discuss challenges of establishing reimbursement system in Russia, ways to promote innovation in the Russian healthcare sector, recent trends in R&D and reimbursement of innovative technologies as well as value based pricing developments at NICE. 
The meeting will be held in English.
ModeratorVitaly V. Omelyanovskiy, MD, PhD, Professor, Director of Center for HTA, Russian Presidential Academy of National Economy & Public Administration, President of ISPOR Russia HTA Chapter

© 2014 Health Technology Assessment in Russia. Send a message         |